Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOB | P04114 | 15/20 | 0.51 |
| ▸ | MTTP | P55157 | 14/20 | 0.51 |
| ▸ | SMO | Q99835 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6804654 | 0.99 | APOB (0.51) | APOBMTTPSMOKDM4E | |
| SCHEMBL6645543 | 0.87 | MTTP (0.61) | APOBMTTPSMOKDM4E | |
| Hydrochloric Acid SCHEMBL6803931 | 0.86 | MTTP (0.60) | APOBMTTPSMOKDM4E | |
| SCHEMBL6808886 | 0.84 | TRPV1 (0.48) | APOBMTTPKDM4E | |
| SCHEMBL6804465 | 0.81 | L3MBTL1 (0.52) | APOBMTTPKDM4E | |
| Hydrochloric Acid SCHEMBL6803617 | 0.81 | L3MBTL1 (0.51) | APOBMTTPKDM4E | |
| SCHEMBL6665641 | 0.80 | APOB (0.51) | APOBMTTPSMO | |
| Hydrochloric Acid SCHEMBL6662670 | 0.79 | APOB (0.50) | APOBMTTPSMO | |
| SCHEMBL6662272 | 0.79 | L3MBTL1 (0.51) | APOBMTTPKDM4E | |
| SCHEMBL6809096 | 0.78 | MAPT (0.62) | APOBMTTPKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040157866-A1 | Amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157866-A1 | Amide compounds | APOB, NR1H2, NR1H3 | APOB 1/4885MTTP 108/4885SMO 4390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.